FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2426863673> ?p ?o ?g. }

• W2426863673 endingPage "82" @default.
• W2426863673 startingPage "74" @default.
• W2426863673 abstract "ObjectiveFew studies have examined the effectiveness of 12-step peer recovery support programs with drug use disorders, especially stimulant use, and it is difficult to know how outcomes related to 12-step attendance and participation generalize to individuals with non-alcohol substance use disorders (SUDs).MethodA clinical trial of 12-step facilitation (N = 471) focusing on individuals with cocaine or methamphetamine use disorders allowed examination of four questions: Q1) To what extent do treatment-seeking stimulant users use 12-step programs and, which ones? Q2) Do factors previously found to predict 12-step participation among those with alcohol use disorders also predict participation among stimulant users? Q3) What specific baseline “12-step readiness” factors predict subsequent 12-step participation and attendance? And Q4) Does stimulant drug of choice differentially predict 12-step participation and attendance?ResultsThe four outcomes variables, attendance, speaking, duties at 12-step meetings, and other peer recovery support activities, were not related to baseline demographic or substance problem history or severity. Drug of choice was associated with differential days of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) attendance among those who reported attending, and cocaine users reported more days of attending AA or NA at 1-, 3- and 6-month follow-ups than did methamphetamine users. Pre-randomization measures of perceived benefit of 12-step groups predicted 12-step attendance at 3- and 6-month follow-ups. Pre-randomization 12-step attendance significantly predicted number of other self-help activities at end-of-treatment, 3- and 6-month follow-ups. Pre-randomization perceived benefit and problem severity both predicted number of self-help activities at end-of-treatment and 3-month follow-up. Pre-randomization perceived barriers to 12-step groups were negatively associated with self-help activities at end-of-treatment and 3-month follow-up. Whether or not one participated in any duties was predicted at all time points by pre-randomization involvement in self-help activities.ConclusionsThe primary finding of this study is one of continuity: prior attendance and active involvement with 12-step programs were the main signs pointing to future involvement. Limitations and recommendations are discussed." @default.
• W2426863673 created "2016-06-24" @default.
• W2426863673 creator A5021423277 @default.
• W2426863673 creator A5027631852 @default.
• W2426863673 creator A5035731887 @default.
• W2426863673 creator A5042485792 @default.
• W2426863673 creator A5044073345 @default.
• W2426863673 creator A5045470354 @default.
• W2426863673 creator A5046577974 @default.
• W2426863673 creator A5050327571 @default.
• W2426863673 creator A5066093323 @default.
• W2426863673 creator A5074149624 @default.
• W2426863673 creator A5074660420 @default.
• W2426863673 creator A5076017614 @default.
• W2426863673 creator A5078397393 @default.
• W2426863673 date "2016-09-01" @default.
• W2426863673 modified "2023-10-18" @default.
• W2426863673 title "Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders" @default.
• W2426863673 cites W1965246039 @default.
• W2426863673 cites W1975271154 @default.
• W2426863673 cites W1982476362 @default.
• W2426863673 cites W1983485685 @default.
• W2426863673 cites W1992431449 @default.
• W2426863673 cites W1993415019 @default.
• W2426863673 cites W1999233251 @default.
• W2426863673 cites W2001318340 @default.
• W2426863673 cites W2003209151 @default.
• W2426863673 cites W2004150863 @default.
• W2426863673 cites W2004730432 @default.
• W2426863673 cites W2006004785 @default.
• W2426863673 cites W2016152994 @default.
• W2426863673 cites W2031587604 @default.
• W2426863673 cites W2032753125 @default.
• W2426863673 cites W2041590582 @default.
• W2426863673 cites W2061131346 @default.
• W2426863673 cites W2065758849 @default.
• W2426863673 cites W2067795033 @default.
• W2426863673 cites W2070370172 @default.
• W2426863673 cites W2073592435 @default.
• W2426863673 cites W2073593166 @default.
• W2426863673 cites W2074641637 @default.
• W2426863673 cites W2079046722 @default.
• W2426863673 cites W2080583421 @default.
• W2426863673 cites W2081062057 @default.
• W2426863673 cites W2091912342 @default.
• W2426863673 cites W2092750148 @default.
• W2426863673 cites W2095210871 @default.
• W2426863673 cites W2102714420 @default.
• W2426863673 cites W2108066932 @default.
• W2426863673 cites W2112850514 @default.
• W2426863673 cites W2113009488 @default.
• W2426863673 cites W2113934226 @default.
• W2426863673 cites W2135578025 @default.
• W2426863673 cites W2136598366 @default.
• W2426863673 cites W2152377180 @default.
• W2426863673 cites W2154896792 @default.
• W2426863673 cites W2158565083 @default.
• W2426863673 cites W2162929520 @default.
• W2426863673 cites W4236180415 @default.
• W2426863673 doi "https://doi.org/10.1016/j.jsat.2016.06.007" @default.
• W2426863673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5462490" @default.
• W2426863673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27431050" @default.
• W2426863673 hasPublicationYear "2016" @default.
• W2426863673 type Work @default.
• W2426863673 sameAs 2426863673 @default.
• W2426863673 citedByCount "7" @default.
• W2426863673 countsByYear W24268636732017 @default.
• W2426863673 countsByYear W24268636732019 @default.
• W2426863673 countsByYear W24268636732020 @default.
• W2426863673 countsByYear W24268636732021 @default.
• W2426863673 countsByYear W24268636732022 @default.
• W2426863673 countsByYear W24268636732023 @default.
• W2426863673 crossrefType "journal-article" @default.
• W2426863673 hasAuthorship W2426863673A5021423277 @default.
• W2426863673 hasAuthorship W2426863673A5027631852 @default.
• W2426863673 hasAuthorship W2426863673A5035731887 @default.
• W2426863673 hasAuthorship W2426863673A5042485792 @default.
• W2426863673 hasAuthorship W2426863673A5044073345 @default.
• W2426863673 hasAuthorship W2426863673A5045470354 @default.
• W2426863673 hasAuthorship W2426863673A5046577974 @default.
• W2426863673 hasAuthorship W2426863673A5050327571 @default.
• W2426863673 hasAuthorship W2426863673A5066093323 @default.
• W2426863673 hasAuthorship W2426863673A5074149624 @default.
• W2426863673 hasAuthorship W2426863673A5074660420 @default.
• W2426863673 hasAuthorship W2426863673A5076017614 @default.
• W2426863673 hasAuthorship W2426863673A5078397393 @default.
• W2426863673 hasBestOaLocation W24268636732 @default.
• W2426863673 hasConcept C118552586 @default.
• W2426863673 hasConcept C126322002 @default.
• W2426863673 hasConcept C15744967 @default.
• W2426863673 hasConcept C162324750 @default.
• W2426863673 hasConcept C168563851 @default.
• W2426863673 hasConcept C204243189 @default.
• W2426863673 hasConcept C2778173179 @default.
• W2426863673 hasConcept C2780557958 @default.
• W2426863673 hasConcept C40010229 @default.
• W2426863673 hasConcept C48856860 @default.
• W2426863673 hasConcept C50522688 @default.

• next